Eterna Therapeutics Inc (ERNA) — Free Cash Flow Generation Index
Eterna Therapeutics Inc (ERNA) has a Free Cash Flow Generation Index of 1.00x as of September 2019. Free cash flow of $88.00 Million represents 1% of operating cash flow ($88.00 Million). Explore capital reinvestment ratio of Eterna Therapeutics Inc to see what proportion of operating cash flow is directed to capital expenditures.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Eterna Therapeutics Inc Free Cash Flow Generation Index (2009–2019)
Historical FCF Generation Index trend for Eterna Therapeutics Inc across 9 annual periods. For the full cash flow conversion analysis, see Eterna Therapeutics Inc (ERNA) cash flow conversion.
Annual Free Cash Flow Generation for Eterna Therapeutics Inc (2009–2019)
Year-by-year Free Cash Flow Generation Index for Eterna Therapeutics Inc. Check ERNA total capital reinvestment ratio to assess the company's total reinvestment commitment from operating cash flow.
| Year | FCG Index | Free Cash Flow (USD) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2019 | 0.60x | $1.65 Million | $2.74 Million | $1.09 Million | ▲ +432.3% |
| 2018 | -0.18x | $-247.00K | $1.36 Million | $1.61 Million | ▲ +89.0% |
| 2017 | -1.64x | $-903.00K | $549.00K | $1.45 Million | ▲ +95.4% |
| 2016 | -35.52x | $-817.00K | $23.00K | $840.00K | ▼ -8491.4% |
| 2013 | 0.42x | $632.00K | $1.49 Million | $861.00K | ▼ -1.9% |
| 2012 | 0.43x | $930.00K | $2.16 Million | $1.23 Million | ▲ +124.3% |
| 2011 | -1.78x | $-1.02 Million | $574.00K | $1.59 Million | ▼ -433.6% |
| 2010 | 0.53x | $1.51 Million | $2.83 Million | $1.32 Million | ▲ +124.8% |
| 2009 | 0.24x | $593.00K | $2.50 Million | $1.91 Million | — |